Mitesh Patel, MD
Sports Medicine · Marlton, NJNPI 1093987034
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.6%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Lilly USA, LLC at 41.3% of the total. Reporting peaked in 2020 at $3,211 and has fallen 82.8% since, to $551 in 2025.
Across 78 payments — averaging $92.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$3K
- Ferring Pharmaceuticals Inc.$2K
- Bioventus LLC$939
- Zimmer Biomet$564
- Amgen$278
- Boston Scientific$193
- plus $380 from 8 others
What the payments were for
- Consulting fees$2,97541%
- Speaking & faculty fees$1,23017%
- Food & beverage$2,99342%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 1 | $2,975 |
| Ferring Pharmaceuticals Inc. | 35 | $1,869 |
| Bioventus LLC | 7 | $939 |
| Zimmer Biomet | 7 | $564 |
| Amgen | 13 | $278 |
| Boston Scientific | 2 | $193 |
| Pacira Pharmaceuticals Incorporated | 1 | $142 |
| Johnson & Johnson | 4 | $68 |
| Pacira Therapeutics, Inc. | 1 | $50 |
| Fidia Pharma USA Inc. | 2 | $34 |
| Endo Pharmaceuticals Inc. | 2 | $30 |
| Avanos Medical | 1 | $20 |
| Orthofix Medical, Inc. | 1 | $19 |
| AbbVie | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EUFLEXXA$1,291
- Exogen Ultrasound Bone Healing System$437
- Gel-One Cross-linked Hyaluronate$363
- RAYOS$343
- Durolane$339
- Iovera$142
- GELSYN 3$130
- GENERAL PAIN MANAGEMENT$100
How this compares
$7,198 in reported general payments places this provider in the 80th percentile of 221 sports medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 14 | $1,750 |
| Methylprednisolone | 211 | $1,287 |
| Diclofenac Sodium | 30 | $740 |
| Tizanidine Hcl | 85 | $345 |
| Tramadol Hcl | 92 | $280 |
| Cyclobenzaprine Hcl | 13 | $213 |
| Gabapentin | 18 | $154 |
| Fluticasone Propionate | 11 | $142 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $94 |
| Meloxicam | 83 | $89 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 13 | $83 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Marlton
- Sunny GuptaMarlton$10K
- Sean McMillanBurlington$1.8M
- Nicholas JarmonFreehold$277K
- Thomas YoumEnglewood$221K
- Stephen HuntCedar Knolls$76K
- David PorterHackensack$63K
- Francis AlbertaHackensack$61K
- Nathan HolmesSewell$56K
- Steven FreyWoodbury$55K
- Lon CastleFranklin Lakes$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.